SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.07+2.7%3:49 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron Flanigan who wrote (3705)6/24/1998 11:33:00 AM
From: DT  Read Replies (1) of 9523
 
Ron,

You make an interesting point RE class action lawsuits and consumer demand for Viagra. Within the pharmacy benefits community, a major consideration regarding Viagra cover/don't cover decisions focuses on existing coverage of other ED products. The HMO executives making the decision to exclude Viagra are aware that by continuing to cover other ED products they are in an extremely vulnerable legal position.

The natural conclusion (IMHO) is that either limited Viagra coverage under certain guidelines will be adopted by most plans or all ED products will be carved out of regular pharmacy benefit plans and offered as an additional rider.

By the way, can anyone tell me the earnings announcement date?

DT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext